Company Performance Metrics
Gerald Clarke: President, Technology/Technologist
Roger Gerlach: President
ReaLens, LLC is an ophthalmic devices manufacturer startup that has two products:
1) A new unique, patented Iris Expander/Stabilizer that prevents Floppy Iris Syndrome during cataract surgery. This product is FDA 510K approved and ready for sale now.
2) The first truly accommodating IntraOcular Lens, that -- after cataract surgery --focuses
naturally at distance, near, and between. This product is in development, and should be available for clinical trials in late 2015
The Iris Expander/Stabilizer is inserted during cataract surgery to prevent Iris Prolapse (expulsion of iris tissue) in at-risk eyes. As many as 10% of all men who have taken prostate medications are at risk to develop Floppy Iris Syndrome during surgery, which is damaging to the delicate Iris Tissues. The potential market for this device is $16 million per year.
The Realens Accommodating IOL is based on the latest theories of human vision and near focusing. Recent advances in cataract surgery have shown that the ciliary muscle inside the eye continues to contract even as we advance in age. When the brittle cataract is removed in surgery, this artificial lens can be implanted inside the eye and will focus just like the natural, youthful lens.
The market for ophthalmic devices and surgical instruments is growing by 10% per year as the population ages. ReaLens, LLC goal is to provide better vision for an aging population.
